EMA pilot offers enhanced support to academic and non-profit developers of advanced therapy medicinal products

Κατηγορία Νέα / Ειδήσεις
Διαβάστηκε 214 φορές

EMA is launching a pilot to support the translation of basic research developments into medicines that could make a difference in patients’ lives in the European Economic Area (EEA). The pilot is open to academic sponsors and non-profit organisations who are developing advanced therapy medicinal products (ATMPs). These medicines for human use are based on genes, tissues or cells and might offer ground-breaking treatment options to patients (read more)

Τελευταία τροποποίηση στις Παρασκευή, 30 Σεπτεμβρίου 2022 10:33